Disposable Syringe Markets - Market Research Reports

Contents:

1. Introduction
1.1 Statement of Report
1.2 About this Report
1.3 Scope of the Report
1.4 Objectives
1.5 Methodology
1.6 Executive Summary

2. Disposable Syringe Markets
2.1 Overview
2.2 Infection Control and Safety
2.2.1 Needlestick Injuries
2.2.2 Availability of Safety Syringes in the U.S. Healthcare Facilities
2.3 Cost of Safety Syringe
2.4 Market Expansion
2.5 Unsafe Injection Practices
2.6 Hospital Consolidations Pressure Companies to Reduce Prices
2.7 Strategic Alliance of Needleless Injector Manufacturers
2.8 Technological Advancements in Disposable Syringes
2.8.1 Reconstitution inside Sterile Syringes
2.8.2 Plungerless Prefilled Syringes
2.8.3 The Disposable UniJect
2.9 Award Winning Syringes
2.9.1 Episure AutoDetect Epidural Syringe
2.9.2 ConfiDose Disposable Autoinjector
2.9.3 Humatrope Reconstitution Device
2.9.4 Vasceze Plungerless Syringe

3. Disposable Syringe Market Segments
3.1 Overview
3.1.1 World Market for Disposable Syringes
3.1.2 U.S. Market for Disposable Syringes
3.1.3 Disposable Syringe Market in India

4. Insulin Syringes
4.1 Insulin Strengths: U-40 and U-100
4.2 Market for Insulin Pen
4.3 Shelf Life of Insulin Pen Cartridges
4.4 An Update on Insulin Injection Devices
4.4.1 Insulin Injection Devices Currently Available in the U.S.
4.4.2 Disposable Pens
4.4.3 Refillable Pens
4.4.4 Pen Needles
4.4.5 Benefits and Patient Preferences
4.4.6 Disadvantages of Pen Syringes
4.4.7 Insulin Pens and the Hospital Bills
4.5 Insulin Pens for Indian Market from IDC
4.6 Expansion of Facilities for Insulin Pens by Eli Lilly and Rexam
4.7 Major Players in Insulin Pens and Syringes
4.7.1 Sanofi-Aventis
4.7.1.1 Sanofi-Aventis' Business in Diabetes Care Segment
4.7.2 Novo Nordisk
4.7.2.1 Novo Nordisk's Diabetes Care Business in North America
4.7.2.2 Novo Nordisk's International Operations
4.7.2.3 Novo Nordisk's Business in Diabetes Care in Europe
4.7.3 Eli Lilly & Co.
4.7.3.1 Byetta
4.7.3.2 Humulin
4.7.3.3 Humalog

5. Safety Syringes
5.1 Available Safety Syringe Technologies
5.1.1 Retrofitted Syringes
5.1.2 Automatically Retractable Syringes
5.1.3 Manually Retractable Syringes
5.2 Safety Syringe Market
5.3 Drivers of Safety Syringes

6. Prefilled Syringes
6.1 Types of Prefilled Syringes (PFS)
6.2 Market for Prefilled Syringes
6.3 The Rise of Prefilled Syringes
6.4 Needle Safety for Prefilled Syringes
6.4.1 V-OVS NS
6.4.2 Preventis
6.4.3 UltraSafe Passive Delivery System/ERYPROSafe and NUFILSafe
6.5 Sterility Maintenance of Prefilled Syringes
6.6 Compatibility of Drugs with the Components of Prefilled Syringes
6.7 Some of the Drugs Available in Prefilled Syringes
6.7.1 Ovidrel PreFilled Syringe
6.7.2 Enbrel Prefilled Syringes
6.7.3 Biocon's Prefilled Safety Syringes
6.7.4 Relistor Prefilled Syringes
6.7.5 PEGASYS
6.7.6 Afluria
6.7.7 Enzira
6.7.8 FluZone Prefilled Syringe for Children
6.7.9 Novolin N FlexPen Prefilled Insulin Syringe
6.7.10 NovoLog Insulin Prefilled Syringe
6.7.11 GlaxoSmithKline's Vaccines in Prefilled Syringes
6.8 U.S. Production of Unilife's Prefilled Syringes
6.9 Some of the Major Providers of Syringe-Prefilling Services and Products
6.9.1 Althea Technologies, Inc.
6.9.1.1 Althea's Clinical Manufacturing
6.9.1.2 Althea's Fill/Finish Services
6.9.1.3 Althea's Contract Manufacturing
6.9.2 Baxter International, Inc.
6.9.2.1 Baxter's Contract Manufacturing
6.9.2.2 Baxter's Fill and Finish Capabilities
6.9.2.3 Baxter's Prefilled Syringes Capability
6.9.2.4 Baxter's Vials
6.9.2.5 Baxter's Cartridges
6.9.3 Becton, Dickinson and Company
6.9.3.1 BD's Prefilled Syringe Services
6.9.3.2 BD Hypak SCF Glass Prefillable Syringes
6.9.3.3 BD Sterifill SCF Plastic Prefillable Syringe Systems
6.9.3.4 BD Physioject Disposable AutoInjector
6.9.3.5 BD MicroInfusor Automatic Injection System
6.9.3.6 BD Liquid Dry Injector Disposable Pen Injector
6.9.3.7 BD Pens Customized Self-Injection Systems
6.9.3.8 BD Soluvia Prefillable Microinjection System
6.9.3.9 BD Preventis Shielding System for Prefilled Syringes
6.9.4 Catalent Pharma Solutions, Inc.
6.9.4.1 The Protector Safety Shield System
6.9.4.2 The ASI Autoinjector and Ultra-Compact ASI Mini Autoinjector
6.9.5 Hyaluron Contract Manufacturing (HCM)
6.9.5.1 Hyaluron's Syringe Filling
6.9.6 Vetter Pharma Fertigung GmbH
6.10 Features of Prefilled Syringes
6.10.1 Dual Chamber Prefilled Syringes

7. Pen Syringes
7.1 Pen Devices for Insulin Delivery
7.2 Technical Advances in Insulin Pens
7.3 Pen Types and Styles
7.4 Prefilled Pens
7.5 Reusable Pens
7.6 Prefilled Autoinjecting Disposable Syringes
7.7 Uniject Injection Device

8. Microneedle
8.1 Electronic Mosquito

9. Needle-free Injectors
9.1 Needle-free Delivery of Liquids
9.2 Needle-free Delivery of Solid Formulations
9.3 Needleless Injector from Injex
9.4 Jet Syringe from Injex
9.5 Syrijet
9.6 PenJet
9.7 Needle-free Injector for Human Growth Hormone

10. Needle and Syringe Market Trends
10.1 Market Segments
10.2 Customer Needs
10.3 Competitor Analysis
10.3.1 Automatic Safety Syringes
10.3.2 Manually Locking Safety Syringes
10.4 Third Party Reimbursement
10.5 Regulation
10.6 Drug Discovery Trends
10.7 Demographic Shifts
10.8 Growth in Home Healthcare

11. Technological Developments
11.1 Auto-Disable Syringes
11.1.1 AD Syringes with Needle Retraction/Disposal Feature
11.1.2 AD Syringe with No Needle Retraction Feature
11.1.3 Needlestick Prevention Syringes
11.1.4 Automatic Needlestick Prevention Feature
11.1.4.1 UltraSafePassive Delivery System
11.1.4.2 Sterimatic Sleeve
11.1.4.3 K3 Safety Cap
11.2 Manual Needlestick Prevention Feature
11.2.1 Safety Lok Syringe
11.2.2 MonojectMagellan

12. Business Trends
12.1 Market Drivers
12.2 Market Prospects
12.3 Marketing and Distribution
12.4 Competitive Landscape
12.5 Future Technologies
12.5.1 Glide Solid Dose Injector (SDI)
12.5.2 BD Physioject

13. Regulatory Measures
13.1 Safety Syringes in Europe

14. Company Profiles
14.1 Abbott Laboratories
14.1.1 HUMIRA Prefilled Syringe
14.1.2 HUMIRA Pen
14.1.3 Precision Sure-Dose Insulin Syringes
14.2 Albert David Limited
14.3 Alshifa Medical Syringes Manufacturing Company Ltd.
14.4 Althea Technologies, Inc.
14.5 Avitro, Inc.
14.6 Baxter International, Inc.
14.6.1 Baxter's Medication Delivery
14.6.2 Baxter's IV Therapies
14.6.3 Baxter's Global Injectables
14.6.4 Baxter's Infusion Systems
14.6.5 Baxter's IV Infusion Pumps and Infusion Sets
14.6.6 Baxter's Pharma Partnering
14.7 Becton, Dickinson and Company (BD)
14.7.1 BD's Role in Designing Devices for Safe and Effective Injections and Infusions
14.7.2 BD's Products
14.8 Boston Scientific Corporation
14.9 B. Braun
14.9.1 The Hospital Care Division
14.9.2 The Aesculap Division
14.9.3 The Out Patient Market (OPM) Division
14.9.4 The B. Braun Avitum Division
14.9.5 B. Braun's Syringe Products
14.10 Bioject Medical Technologies, Inc.
14.10.1 Biojector 2000
14.10.2 Drug Reconstitution System
14.10.3 Vitajet
14.10.4 Cool.click
14.10.5 SeroJet
14.11 Catalent Pharma Solutions, Inc.
14.11.1 Catalent's Oral Technologies Segment
14.11.2 Catalent's Sterile Technologies Segment
14.11.3 Catalent's Packaging Services Segment
14.11.4 Catalent's Manufacturing Capabilities
14.11.5 Catalent's Employee Strength
14.11.6 Catalent's Syringes
14.12 C.R. Bard, Inc.
14.12.1 Bard's Vascular Business
14.12.2 Bard's Urology Business
14.12.3 Bard's Oncology Business
14.12.4 Bard's Business in Surgical Specialties
14.12.5 Bard's Overseas Expansion
14.12.6 Bard's Bulb Syringes and Trays
14.12.7 Bard's Piston Syringes and Trays
14.13 Coeur, Inc.
14.13.1 Angiographic Syringes from Coeur, Inc.
14.13.2 CT Syringes from Coeur, Inc.
14.14 Covidien Ltd.
14.14.1 Covidien's Medical Devices Segment
14.14.2 Covidien's R&D
14.14.3 Covidien's Competitors in Medical Devices
14.14.4 Covidien's Syringes
14.15 Henke-Sass, Wolf GmbH
14.15.1 Two-Part Disposable Syringes 1-50(60) ml
14.15.2 Three-Part Disposable Syringes 1-30 ml
14.15.3 Disposable Needles HSW FINE-JECT
14.16 Hindustan Syringes & Medical Devices, Ltd. (HMD)
14.16.1 Insulin Syringes from HMD
14.16.2 HMD's Single Use Needles
14.16.3 HMD's Single Use Syringes
14.17 Hi-Tech Medical Products Ltd.
14.18 Hyaluron Contract Manufacturing
14.18.1 HCM's Major Markets
14.18.2 HCM's Facility
14.19 International Medication System Ltd.
14.19.1 Delivery Systems from IMS
14.19.2 PCA Products from IMS
14.19.3 Phytonadione Injection USP
14.19.4 Lidocaine HCl Jelly, USP 2% (Preservative-free)
14.20 Life-Shield Products, Inc.
14.21 Merit Medical Systems, Inc.
14.21.1 Merit's Products
14.21.2 Merit's Vascular Access Products
14.21.3 Merit's Business in the U.S.
14.21.4 Merit's International Business
14.21.5 Merit's Customers
14.21.6 Merit's R&D
14.21.7 Merit's Manufacturing Facilities
14.22 Milestone Scientific
14.22.1 Milestone Scientific's Product Platform
14.22.2 Milestone Scientific's Investment in R&D
14.22.3 Milestone Scientific's Business Performance
14.23 Novo Nordisk A/S
14.23.1 Novo Nordisk's Business in Diabetes Care Segment
14.23.2 Novo Nordisk's Modern Insulins, Human Insulins and Insulin-related Products
14.23.3 Novo Nordisk's Geographic Performance in Diabetes Care Products
14.23.4 Pipeline Progress in Nova Nordisk
14.23.5 Novo Nordisk's Modern Insulin Portfolio
14.24 Owen Mumford Ltd.
14.24.1 Owen Mumford's Global Locations
14.24.2 Owen Mumford's Products
14.25 Plas-Pak Industries, Inc.
14.25.1 Dial-A-Dose Disposable Veterinary Syringes
14.25.2 Dual Syringe and Dental Syringe from Plas-Pak
14.25.3 Mini Dual Syringe
14.25.4 Manual Dual Syringes
14.26 Retractable Technologies, Inc.
14.26.1 Retractable Technologies' Principal Products
14.26.2 Retractable Technologies' Principal Markets
14.26.3 Retractable Technologies' R&D
14.26.4 Retractable Technologies' VanishPoint Products
14.27 Revolutions Medical Corporation
14.27.1 Rev Vac Safety Syringe
14.28 Safety Syringes, Inc.
14.28.1 Custom Engineering from Safety Syringes, Inc.
14.28.2 Syringe Products from Safety Syringes, Inc.
14.29 Smiths Medical International/Medex, Inc.
14.29.1 Smiths Medical's Markets
14.29.2 Smiths Medical's Medication Delivery Segment
14.29.3 Smiths Medical's Vital Care Segment
14.29.4 Smiths Medical's Safety Devices Segment
14.29.5 Smiths Medical's Business Performance
14.29.6 Smiths Medical's Business Performance on Geographic Basis
14.29.7 Smiths Medical's R&D
14.29.8 Syringes from Smiths Medicals
14.30 Specialized Health Products International, Inc.
14.30.1 SHPI's Products and Services
14.30.2 SHPI's Licensed Products
14.31 Star Syringe Ltd.
14.31.1 Star Alliances
14.31.2 Preoducts from Star Syringe Ltd.
14.32 Terumo's Medical Corporation
14.32.1 Terumo's General Hospital Products
14.32.2 Terumo's Diabetes Care Products
14.32.3 Terumo's Syringe Products
14.33 UltiMed, Inc.
14.33.1 UltiCare Insulin Syringes
14.33.2 UltiCare Pen Needles
14.34 Unilife Medical Solutions, Ltd.
14.34.1 Pharmaceutical Market for Unilife's Prefilled Syringes
14.34.2 Unilife Partnership with Sanofi-Aventis
14.34.3 Unilife's Licensing Agreement with Sanofi-Aventis
14.34.4 Unilife's Partnership with Gerresheimer Bunde
14.34.5 Unilife's Portfolio of Safety Syringes
14.34.6 Unilife's Prefilled Syringes
14.34.7 Unilife's Contract Manufacturing Activities
14.34.8 Unilife's Performance in Syringe Market
14.35 Vetter Pharma-Fertigung GmbH & Co., KG
14.35.1 Vetter Services and Solutions
14.35.2 Dual-Chamber Technology
14.36 Vita Needle Company, Inc.
14.36.1 Disposable Stainless Steel Needle Blunts from Vita Needle
14.36.2 Teflon Dispensing Needles
14.36.3 Vita Needle's Polypropylene Needles
14.36.4 Vita Needle's Taper Tip Needles
14.37 West Pharmaceutical Services, Inc.
14.37.1 West's Pharmaceutical Systems Segment
14.37.2 West's Tech Group Segment
14.37.3 West's R&D Activities
14.37.4 West's Syringe Products
14.38 Wuxi Yushou Medical Appliances Co., Ltd.
14.39 Ypsomed Holding AG
14.39.1 Ypsomed's Injection Systems
14.39.2 Ypsomed's Insulin Delivery Systems
14.39.3 Additional Indication Areas for Pen Systems
14.39.4 Ypsomed's Innovative Injection Systems at a Glance
14.39.5 Ypsomed's Complete Product Range for Insulin Suppliers
14.39.6 Ypsomed's New Dual-Chamber Injecting Systems
14.39.7 Ypsomed's ServoPen
14.39.8 Growth of Ypsomed's Pen Needles
14.39.9 Ypsomed's Performance in 2008/2009
14.39.10 Ypsomed's R&D
14.40 The Medical House PLC (TMH)
14.40.1 TMH's Products

Appendix 1: U.S. Healthcare Expenditure Projections, 2008-2018
Appendix 2: Syringe Needle Terminology
Appendix 3: Medication Errors and Syringe Safety
Appendix 3.1: Injectable Medication Errors
Appendix 3.2: Frequency of Syringe Usage
Appendix 3.3: Labeling Injectable Medications
Appendix 3.4: Challenges of Labeling
Appendix 3.5: Benefits of a Write-On Stripe
Appendix 3.6: Nurses Influence on Selection of Sharp Devices
Appendix 3.7: Needlestick Injuries
Appendix 3.8: Prevention of Needlestick Injuries
Appendix 3.9: Protection from Needlestick Injuries

INDEX OF FIGURES

Figure 2.1: Principal Causes of Needlestick Injuries
Figure 2.2: Availability of Safety Syringes in the U.S. Healthcare Facilities, 2008
Figure 3.1: Worldwide Unit Market for Syringes and Needles, 2004-2012
Figure 3.2: Global Syringe Market, 2009
Figure 3.3: Worldwide Market for Disposable Syringes and Needles, 2004-2012
Figure 3.4: U.S. Market for Disposable Syringes and Needles, 2006-2013
Figure 3.5: Market Segments of the U.S. Syringe Market, 2009
Figure 3.6: E.U. Market for Syringes, Needles and Catheters, 2007 and 2008
Figure 3.7: Worldwide Market Share for Hypodermic Syringes, 2009
Figure 3.8: Disposable Syringe Market in India, 2008-2012
Figure 3.9: Market Share for Disposable Syringes in India, 2008
Figure 3.10: Market Share for Disposable Needles in India, 2008
Figure 4.1: Market Growth for Insulin Pen, 2007-2014
Figure 4.2: Market Growth for Insulin Pens in Europe, 2007-2014
Figure 4.3: Global Sales Performance of Sanofi-Aventis' Lantus, 2007 and 2008
Figure 4.4: Global Sales Performance of Sanofi-Aventis' Amaryl, 2007 and 2008
Figure 4.5: Sales Performance of Sanofi-Aventis' Lantus by Geography, 2008
Figure 4.6: Novo Nordisk's Business Performance in Diabetes Care by Geography, 2008
Figure 4.7: Novo Nordisk's Performance in Diabetes Care, 2004-2008
Figure 4.8: Eli Lilly's Business Performance in Byetta, 2006 and 2007
Figure 4.9: Eli Lilly's Business Performance in Humulin, 2006-2008
Figure 4.10: Eli Lilly's Sales Performance in Humalog, 2006-2008
Figure 5.1: Growth of Safety Syringe Market, 2008-2012
Figure 6.1: Market Growth for Prefilled Syringes, 2009-2013
Figure 6.2: Growth of Prefilled Syringes Market in E.U., 2008-2012
Figure 10.1: Breakdown of U.S. Syringe Market, 2009
Figure 10.2: U.S. Home Healthcare Products Market, 2007-2012
Figure 14.1: Abbott's Global Business Performance by Country, 2008
Figure 14.2: Abbott's Global Business Performance, 2004-2008
Figure 14.3: Baxter's Performance in Medication Delivery Segment, 2008
Figure 14.4: Baxter's Performance in IV Therapies, 2006-2008
Figure 14.5: Baxter's Performance in Injectables, 2006-2008
Figure 14.6: Baxter's Performance in Infusion Systems, 2006-2008
Figure 14.7: BD's Performance in Safety-engineered Devices, 2007 and 2008
Figure 14.8: BD's International Performance in Safety-engineered Devices, 2007 and 2008
Figure 14.9: Business Performance by B. Braun's Hospital Care Division, 2006-2008
Figure 14.10: Business Performance by B. Braun's Aesculap Division, 2006-2008
Figure 14.11: Business Performance by B. Braun's Out Patient Market Division, 2006-2008
Figure 14.12: Business Performance by B. Braun's Avitum Division, 2006-2008
Figure 14.13: B. Braun's Business Performance by Geographic Region, 2008
Figure 14.14: Share of Bioject's Business with its Prominent Customers, 2007
Figure 14.15: Bioject's Business Performance by Product Line, 2007
Figure 14.16: Biotech's Business Performance in the U.S. and Other Countries, 2007
Figure 14.17: Catalent's Business Performance, 2004-2008
Figure 14.18: Catalent's Business Performance in its Oral Technologies Segments 2007 and 2008
Figure 14.19: Catalent's Business Performance in its Sterile Technologies Segment, 2007 and 2008
Figure 14.20: Catalent's Business Performance in its Packaging Services Segment, 2007 and 2008
Figure 14.21: Catalent's Employee Strength by Region, 2008
Figure 14.22: Bard's Business Performance in its Vascular Segment, 2004-2008
Figure 14.23: Bard's Business Performance in its Urology Segment, 2004-2008
Figure 14.24: Bard's Business Performance in its Oncology Segment, 2004-2008
Figure 14.25: Bard's Business Performance in its Surgical Specialties Segment, 2004-2008
Figure 14.26: Business Performance of Covidien's Medical Device Segment 2006-2008
Figure 14.27: Covidien's Investment in R&D, 2006-2008
Figure 14.28: Covidien's Business Performance in Syringes (Sharp Safety Products), 2006-2008
Figure 14.29: Merit's Business Performance, 2004-2008
Figure 14.30: Merit's Investment in R&D, 2004-2008
Figure 14.31: Milestone Scientific's Investment in R&D, 2007 and 2008
Figure 14.32: Milestone Scientific's Domestic Business Performance, 2007 and 2008
Figure 14.33: Milestone Scientific's International Business Performance, 2007 and 2008
Figure 14.34: Novo Nordisk's Sales Performance of Diabetes Care Products, 2004-2008
Figure 14.35: Novo Nordisk's Sales Performance in Modern Insulins (Insulin Analogues), 2004-2008
Figure 14.36: Retractable Technologies' Business Performance, 2004-2008
Figure 14.37: Retractable Technologies' Domestic Business Performance, 2006-2008
Figure 14.38: Retractable Technologies' International Business Performance, 2006-2008
Figure 14.39: Retractable Technologies' Investment in Research and Expenditure, 2006-2008
Figure 14.40: Smiths Medical's Business Performance, 2007 and 2008
Figure 14.41: Smiths Medical's Business Performance by Segment, 2007
Figure 14.42: SHPI's Sales Performance, 2006 and 2007
Figure 14.43: SHPI's Revenue from Royalties, 2006 and 2007
Figure 14.44: Terumo's Business Performance in Prefilled Syringes, 2005-2007
Figure 14.45: Terumo's Business Performance in Diabetes Care, 2003-2007
Figure 14.46: West's Business Performance in Pharmaceutical Systems Segment, 2006-2008
Figure 14.47: West's Business Performance in Tech Group Segment, 2006-2008
Figure 14.48: West's Investment in R&D in Pharmaceutical Systems Segment, 2006-2008
Figure 14.49: West's Investment for R&D in Tech Group Segment, 2006-2008
Figure 14.50: Global Prevalence of Diabetes, 2008-2025
Figure 14.51: Prevalence of Diabetes in India, 2008-2025
Figure 14.52: Prevalence of Diabetes in China, 2008-2025
Figure 14.53: Ypsomed's Sales Performance, 2006/2007 and 2008/2009
Figure 14.54: Ypsomed's Sales Performance by Geography, 2008/2009
Figure 14.55: Ypsomed's R&D Expenditure, 2006/2007 and 2008/2009
Figure 14.56: TMH's Business Performance, 2006-2008
Figure 14.57: TMH's Business Performance by Geography, 2008
Figure A1.1: National Health Expenditure in the U.S., 2009-2014
Figure A1.2: National Health Expenditure as a Percent of GDP, 2009-2014
Figure A1.3: Health Expenditure Per Capita, 2009-2014
Figure A1.4: Home Healthcare Expenditure, 2009-2014
Figure A1.5: Prescription Drug Expenditure, 2009-2014
Figure A1.6: Other Non-Durable Medical Products Expenditure, 2009-2014
Figure A1.7: Nursing Home Care Expenditure, 2009-2014
Figure A1.8: Dental Service Expenditure, 2009-2014
Figure A1.9: Hospital Care Expenditure, 2009-2014
Figure A1.10: Physician and Clinical Services Expenditure, 2009-2014
Figure A1.11: Personal Healthcare Expenditure, 2009-2014
Figure A3.1: Timing of Needlestick Injuries

INDEX OF TABLES

Table 4.1: Shelf Life of Insulin Pen Cartridges
Table 4.2: Major Insulin Pen Devices Currently Available in the U.S., 2008
Table 10.1: Highlights of Several Leaders in the Disposable Safety Syringe Market
Table 14.1: Albert David's Syringes with Needles, 2009
Table 14.2: Albert David's Needles, 2009
Table 14.3: BD's Auto-Disable Syringes
Table 14.4: Insulin Syringes from BD, 2009
Table 14.5: BD's Allergy Syringes
Table 14.6: BD's Tuberculin Syringes
Table 14.7: BD's Syringes and Needles (Sterile, Single-Use)
Table 14.8: BD's Safety-Lok Safety-Syringes
Table 14.9: BD's SafetyGlide Syringes
Table 14.10: BD's Eclipse Syringes
Table 14.11: BD's Integra Syringes
Table 14.12: BD's PosiFlush Prefilled Syringes
Table 14.13: Bard's Piston Syringes and Trays, 2009
Table 14.14: Bard's Bulb Syringes and Trays, 2009
Table 14.15: Angiographic Syringes from Coeur, Inc., 2009
Table 14.16: CT Syringes from Coeur, Inc., 2009
Table 14.17: HMD's Dispovan Insulin Syringes, 2009
Table 14.18: HMD's Single Use Needles, 2009
Table 14.19: HMD's Single Use Syringes, 2009
Table 14.20: Hi-Tech Single-Use Syringes, 2009
Table 14.21: Hi-Tech's Single Use Insulin Syringes, 2009
Table 14.22: HCM's Contract Manufacturing Categories, 2009
Table 14.23: Syringes from IMS, 2009
Table 14.24: PCA Syringe from IMS, 2009
Table 14.25: Phytonadione Injection USP from IMS, 2009
Table 14.26: Lidocaine Prefilled Syringes from IMS, 2009
Table 14.27: Life-Shield's Syringe Products, 2008
Table 14.28: Autopen Products from Owen Mumford, 2008
Table 14.29: Unifine Products from Owen Mumford, 2008
Table 14.30: Autoject Products from Owen Mumford, 2008
Table 14.31: Retractable Technologies' VanishPoint Syringes, 2009
Table 14.32: Smiths' Pro Fixed Needle TB Syringe, 2009
Table 14.33: Smiths' Needle-Pro Needle with Needle Protection Device
Table 14.34: Smiths' Needle-Pro Syringe and Needle with Needle Protection Device, 2009
Table 14.35: Smiths' Needle-Pro Needle Protection Device for Insulin Injections, 2009
Table 14.36: Smiths' Needle-Pro Fixed Needle Insulin Syringe
Table 14.37: SurGard2 Syringes with Safety Needle, 2009
Table 14.38: Terumo's SurGuard2 Safety Needles, 2009
Table 14.39: Terumo's Hypodermic Needles, 2009
Table 14.40: Terumo's Hypodermic Syringes without Needle, 2009
Table 14.41: Terumo's Tuberculin Syringes, 2009
Table 14.42: Terumo's Hypodermic Syringes with Needle
Table 14.43: Terumo's SurSaver 1 cc Syringes with Low Dead Space, 2009
Table 14.44: Terumo's Dental Needles, 2009
Table 14.45: Terumo's Spinal Needles, 2009
Table 14.46: Terumo's SurGuard Safety Insulin Syringes, 2009
Table 14.47: Terumo's Insulin Syringes, 2009
Table 15.48: Thinpro's Insulin Syringes, 2009
Table 15.49: UltiMed's UltiCare Insulin Syringes, 2009
Table 14.50: UltiCare Pen Needles, 2009
Table 14.51: Vita Needle's Stainless Steel Needle Blunts, 2009
Table 14.52: Vita Needle's Teflon Dispensing Needles, 2009
Table 14.53: Vita Needle's Polypropylene Needles, 2009
Table 14.54: Vita Needle's Taper Tip Needles, 2009
Table 14.55: Ypsomed's Product Roadmap, 2009-2013
Table 14.56: Ypsomed's Innovative Platforms